With the recent development of clinical two-photon microscopes or endoscopes, new photosensitisers for two-photon photodynamic therapy are the subject of increasing interest. Herein, we review the advances within the ten last years of molecular two-photon photosensitisers.

A complete one- and two-photon spectroscopic and photophysical characterization of three diketopyrrolopyrrole (DPP)–porphyrin conjugates is reported. The increased conjugation introduced by the incremental addition of one, two and four DPP units on the meso porphyrin positions strongly affects the optical properties of the systems. Ground and triplet excited state absorption spectra show a gradual broadening and bathochromic shift and a trend to lower energies is also observed for both fluorescence and phosphorescence emission. Interestingly, the fluorescence quantum yield increases along the series, leading to remarkable NIR emission properties for the larger derivatives. Unlike the model porphyrin, all derivatives exhibit high two-photon absorption activity. An increase in two-photon absorption cross-section in the regions 800–840 nm and 910–930 nm is observed moving from one DPP to two DPP appended units, with a value of the order of 4000 GM at 910 nm for the latter system. The four compounds show high efficiency in generating singlet oxygen, with yields ranging from 0.7 to 0.5, envisaging favourable applications in both one- and two-photon photodynamic therapies. A detailed theoretical exploration of both linear (absorption and emission) and non-linear (two-photon absorption) properties proposes an analysis of the experimental spectra and a comprehensive interpretation of the two-photon activity within the series of compounds.

With the aim of engineering multifunctional nanoparticles useful for cancer therapy, a diketopyrrolopyrrole-porphyrin based photosensitizer was here conjugated to a block copolymer (Pluronic F108), and used to stabilize in water lipidic cubic liquid crystalline nanoparticles (cubosomes), also loaded with the antineoplastic agent docetaxel. The physicochemical characterization by SAXS, DLS, and cryo-TEM demonstrated that the formulation consisted of cubosomes, about 150 nm in size, possessing a bicontinuous cubic structure (space group Pn3m). The cellular imaging experiments proved that these nanoparticles localized in lysosomes and mitochondria, while cytotoxicity tests evidenced a slight but significant synergistic effect which, after irradiation, increased the toxicity induced by docetaxel alone, allowing further reduction of cell viability.

Magnetic resonance imaging (MRI) is a powerful non-invasive diagnostic tool that can provide important insights for medical treatment monitoring and optimization. Photodynamic therapy (PDT), a minimally invasive treatment for various types of tumors, is drawing increasing interest thanks to its temporal and spatial selectivity. The combination of MRI and PDT offers real-time monitoring of treatment and can give significant information for drug-uptake and light-delivery parameters optimization. In this review we will give an overview of molecular theranostic agents that have been designed for their potential application in MRI and PDT.